On Nov. 21, the MLSC team join state, local, and industry leaders to celebrate Sartorius Stedim Biotech’s new Center for Bioprocess Innovation in Marlborough, Massachusetts. The state-of-the-art facility is designed to foster collaboration, co-development and learning on site with customers and other external innovation partners, applying Sartorius’ latest technologies in real-life bioprocess workflows.
The 63,000-square-foot facility houses research and service laboratories, as well as facilities for customer demos and trainings. Dedicated expert teams will offer process development, optimization and validation services. Currently hosting a team of 50 scientists and product developers, the new hub will have the capacity to accommodate more than 120 internal and external bioprocessing experts.
”The Greater Boston area is home to an unparalleled ecosystem that fosters innovation, collaboration, and growth. As a global hub for biotechnology and life sciences, it offers access to world-renowned academic institutions, cutting-edge research facilities, and a highly skilled workforce. Moreover, the region’s robust network of venture capital firms and industry partnerships provides ample opportunities for strategic collaborations. This is an ideal time and a great place to launch these capabilities which are so critical to the success of our customers,” said Maurice Phelan, President of Sartorius North America.
